Chris Snyder
Economist (Dartmouth) and co-director involved with the Market Shaping Accelerator who explains advanced market commitments and economic incentives for drug development and repurposing.
Best podcasts with Chris Snyder
Ranked by the Snipd community
374 snips
Feb 20, 2026 • 52min
664. Are Thousands of Medical Cures Hiding in Plain Sight?
Chris Snyder, economist at Dartmouth who designs market incentives; Heather Stone, FDA policy analyst who built the CureID registry; David Fajgenbaum, physician-scientist who survived Castleman disease and leads EveryCure. They explore drug repurposing, AI and knowledge graphs to match drugs to diseases, crowdsourced registries for real-world cases, and economic pull incentives to make trials and generic repurposing viable.
Jun 12, 2024 • 1h 9min
How to Shape a Market
Chris Snyder, a Non-Resident Senior Fellow at the Institute for Progress and an economics professor at Dartmouth, dives deep into Advanced Market Commitments (AMCs). He discusses the unexpected collaboration of the U.S. and Russia in funding innovations. Snyder reveals why certain diseases like malaria didn't get AMCs, while cancer and Alzheimer’s may be poor candidates. He explores the complexities of vaccine funding and the vital role of organizations like the Gates Foundation in enhancing vaccine distribution, emphasizing the need for a balanced approach to health challenges.
